Navigation Links
Takeda Submits New Drug Application in the U.S. for Investigational Type 2 Diabetes Therapy, Fixed-Dose Combination Alogliptin/Metformin
Date:11/23/2011

OSAKA, Japan and DEERFIELD, Ill., Nov. 23, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) announced today that its wholly-owned subsidiary Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for the fixed-dose combination therapy alogliptin/metformin, which combines alogliptin with metformin in a single tablet. The FDA is expected to review the NDA submission within the next ten months, the standard review period for a new application.

"This NDA submission further extends Takeda's commitment to offering patients with type 2 diabetes a range of therapeutic options to help them manage their condition," noted Thomas Strack, M.D., vice president, clinical science, Takeda Global Research & Development Center, Inc., U.S. "The worldwide incidence of type 2 diabetes continues to expand at a rapid rate and we continue our research into additional medications to treat these patients."

Alogliptin is a selective dipeptidyl peptidase IV inhibitor (DPP-4i) under investigation in the U.S. for the treatment of type 2 diabetes as an adjunct to diet and exercise. Discovered by Takeda San Diego, Inc., alogliptin is designed to slow the inactivation of incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide), which play roles in regulating blood glucose levels. Metformin is a widely used diabetes medication that acts primarily by reducing the amount of glucose produced by the liver. These medications work in combination to help patients with type 2 diabetes manage their blood glucose levels.  

Common adverse reactions reported in greater than or equal to 5 percent of patients treated with co-administration of alogliptin with metformin were: upper respiratory tract infection, nasopharyngitis, creatinine renal clearance decreased, diarrhea, headache, hypertension, and urina
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. U.S. Food and Drug Administration (FDA) Delays Review of Takedas Investigational Type 2 Diabetes Therapies, Alogliptin and Alogliptin/Pioglitazone
2. Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
3. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
4. Takeda Completes Acquisition and Names New CEO of Nycomed
5. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
6. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
7. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
8. Takeda to Acquire Nycomed
9. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
10. Intra-Cellular Therapies and Takeda Enter into Worldwide Collaboration to Develop and Commercialize Compounds for Schizophrenia
11. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015  Shareholder rights law firm Robbins ... officers and directors of Eleven Biotherapeutics, Inc. (NASDAQGM: EBIO) ... is a clinical-stage biopharmaceutical company that engages in ... treat eye diseases, primarily in the ... this press release on the law firm,s Shareholder ...
(Date:5/28/2015)... -- The amount Americans spend on healthcare out of ... of 8% will reach $608 billion by 2019.  Americans ... expenditures, co-pays as part of office visits and hospital ... made its finding in its most recent report ... . Information on the report ...
(Date:5/28/2015)... , May 28, 2015 ... Testing Market - Size, Industry Analysis, Trends, Opportunities, Growth and ... reach $3.6 billion by 2020. The secondary syphilis testing ... 2020. Latin America , ... (LAMEA) market accounted for about 43% revenue share ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 3Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3
... Inc. (Nasdaq: OMCL ) a leading provider of ... present at the UBS 21st Annual Global Healthcare Services Conference ... Omnicell Speakers: Rob Seim, vice president & CFO ... Tuesday, February 8, 2011Time: 11:00 a.m. ESTLocation: Grand ...
... 2011 Carrot Medical, a leading designer of integrated ... During the year, Carrot Medical achieved significant growth in ... private financing. Carrot Medical, recognized as a ... Technology solution that integrates medical images and other visual ...
Cached Medicine Technology:Omnicell to Present at the UBS 21st Annual Global Healthcare Services Conference 2Carrot Medical Reports 2010 Growth in Sales and Financing, Optimism for 2011 2
(Date:5/28/2015)... May 28, 2015 ISMETT , a ... Italy, boosted the Sicilian economy by €132.5 million in expenditure ... benefit of more than €73 million by retaining patients who ... to a new study by the Battelle Memorial Institute. At ... research, training and advanced health care management that is transforming ...
(Date:5/28/2015)... May 28, 2015 Workers’ compensation costs per ... state, a recent study by the Workers Compensation Research ... a three-year period. , The WCRI study, CompScope™ Benchmarks ... workers missed seven days or more of work with those ... average 2011 Michigan claim was 4 percent lower than similar ...
(Date:5/28/2015)... Baptist Medical Center Jacksonville has added ... acute stroke or other neurological conditions. , The new ... few in the country and the first in Florida ... as brain aneurysms. , “Baptist Health is committed ... who are impacted by stroke,” said Nicole Thomas, Baptist ...
(Date:5/28/2015)... 2015 Dr. Paul Vitenas, one of ... announced that the new Houston Surgery Center he recently ... Accreditation of Ambulatory Surgery Facilities awarded this accreditation to ... , According to Dr. Vitenas, the certificate was given ... a Class C ambulatory surgery facility. This certification means ...
(Date:5/28/2015)... Francisco,CA (PRWEB) May 28, 2015 ... creating technology that advances sexual health and wellbeing ... the University of San Francisco (USF) will be ... college sexual assault recording and reporting system. ... empowering, transparent, and confidential reporting experience for college ...
Breaking Medicine News(10 mins):Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3Health News:Michigan Workers’ Compensation Costs Lower Than Most States, Says WCRI Study 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3Health News:Dr. Paul Vitenas’ New Houston Surgery Center Receives AAAASF Accreditation 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3
... of the most effective weapons to stop the spread of ... Haiti since the devastating earthquake last year. A technique ... workers to test water sources that could be contaminated with ... coated onto iron oxide nanoparticles and then added to a ...
... say their efforts in the laboratory may lead to ... but chemistry students in the School of Science ... the science of chemistry they are actually synthesizing molecules ... as potential drug treatments or cures for such devastating ...
... we advise about alcohol consumption?" was recently published by Maurizio ... Leon argues that the message of health benefits of moderate ... in the general population." His reasons included (1) many ... consumption of wine, beer or spirits, and alcohol metabolism may ...
... Blondie singer Debbie Harry and The Verve,s Richard Ashcroft. They ... raise funds for PDT. The work carried out by ... School and Royal Cornwall Hospital in Truro, UK, was ... 30,000, which came from the proceeds of the concert. ...
... at a busy intersection flashes the WALK sign, people with ... it across the street in time. New Northwestern Medicine research ... walk fast enough if they lead physically active lives. ... they can walk," said Dorothy Dunlop, associate professor of medicine ...
... , TUESDAY, Jan. 18 (HealthDay News) -- Stringent mental health ... and behavioral problems among U.S. Army soldiers in Iraq by ... other things, suicidal thoughts and actions fell by half, according ... Tuesday in advance of publication in an upcoming print issue ...
Cached Medicine News:Health News:Special sugar, nanoparticles combine to detect cholera toxin 2Health News:Special sugar, nanoparticles combine to detect cholera toxin 3Health News:Molecules made by IUPUI students may have potential to cure diseases 2Health News:Molecules made by IUPUI students may have potential to cure diseases 3Health News:Critique 029: What should we advise about alcohol consumption? A debate amongst scientists 2Health News:When you can't walk fast enough to cross busy streets 2
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Medicine Products: